AI Science Tracker

AlphaFold structure analysis helps reveal PHGDH transcriptional activity linked to Alzheimer’s amyloid pathology

University of California San Diego; collaborating biomedical research institutions · 23 Apr 2025 · biology

Discovery

AlphaFold structure analysis helps reveal PHGDH transcriptional activity linked to Alzheimer’s amyloid pathology

AlphaFold-based structural analysis highlighted a helix-helix-turn-helix subdomain in PHGDH that resembles a TALE homeodomain, prompting tests of a previously unrecognized DNA-binding and transcriptional function. Experiments supported PHGDH binding to promoters and activation of IKKα and HMGB1 in astrocytes, independently of its metabolic enzyme activity. In mouse models and human brain organoids, PHGDH expression promoted amyloid pathology; a blood-brain-barrier-permeable inhibitor of its transcriptional function reduced amyloid pathology and improved measured behavioral deficits in mice.

Technology: AlphaFold structure prediction, followed by structural comparison of the predicted PHGDH fold

Family AlphaFold: profile · models page

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: AlphaFold-based structural analysis highlighted a helix-helix-turn-helix subdomain in PHGDH that resembles a TALE homeodomain, prompting tests of a previously unrecognized DNA-binding and transcriptional function.
  • Still unknown: The AlphaFold-derived structural resemblance generated the mechanistic hypothesis; experiments establish the reported PHGDH transcriptional and pathology effects in the tested models. The inhibitor and behavioral effects were tested in mice, not people. Human brain organoid findings are in vitro and do not establish clinical disease causation or treatment efficacy. PHGDH overexpression alone did not reproduce all Alzheimer’s disease features, and no human therapeutic outcome is reported.
  • AI role: The researchers inspected AlphaFold-predicted PHGDH structure and identified a helix-helix-turn-helix subdomain resembling a TALE homeodomain, which motivated the hypothesis and targeted mutation tests for DNA binding. AlphaFold did not establish PHGDH function or disease causality; the transcriptional activity and pathology effects were tested through biochemical, cellular, organoid and mouse experiments.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12204802/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 20 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.